Article
Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
Oncotarget - 17 Jan 2017
Paulucci David J, Sfakianos John P, Skanderup Anders J, Kan Kathleen, Tsao Che-Kai, Galsky Matthew D, Hakimi A Ari, Badani Ketan K
Abstract excerpt
Significant disparities in survival, incidence and possibly response to current therapies exist between black and white patients with renal cell carcinoma (RCC). Recent genomic evidence to account for these disparities has been reported for clear cell RCC. However, racial disparities at the genomic level for papillary RCC (pRCC) which is a genetically distinct and less responsive histologic subtype of RCC have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.